title: Synthesis of [11C]SSR149415 and preliminary imaging studies using positron emission tomography.
abstract: SSR149415 was the first non-peptide vasopressin-(V(1b)) receptor antagonist reported. It has been used to probe the role of V(1b) receptors in animal models of depression, aggression, and stress-anxiety, and was progressed to clinical trials for the treatment of depression. Due to the interest in V(1b) receptors as a therapeutic target and the growing use of SSR149415 in preclinical research, we developed a method to label SSR145419 with carbon-11 and have studied its pharmacokinetics in non-human primates using positron emission tomography.
authors.affiliation: Brookhaven National Laboratory, Medical Department, Upton, NY 11973, USA.
authors.forename: Matthias
authors.initials: M
authors.lastname: Schönberger
authors.forename: Carmine
authors.initials: C
authors.lastname: Leggett
authors.forename: Sung Won
authors.initials: SW
authors.lastname: Kim
authors.forename: Jacob M
authors.initials: JM
authors.lastname: Hooker
mesh_terms: D000818:Animals; D014151:Anti-Anxiety Agents / Q000138:chemical synthesis* / Q000737:chemistry / Q000493:pharmacokinetics; D065092:Antidiuretic Hormone Receptor Antagonists; D001007:Anxiety / Q000188:drug therapy; D002250:Carbon Radioisotopes / Q000737:chemistry; D003863:Depression / Q000188:drug therapy; D007211:Indoles / Q000138:chemical synthesis* / Q000737:chemistry / Q000493:pharmacokinetics; D010215:Papio; D049268:Positron-Emission Tomography; D011759:Pyrrolidines / Q000138:chemical synthesis* / Q000737:chemistry / Q000493:pharmacokinetics; D017483:Receptors, Vasopressin / Q000378:metabolism
chemical_list: C456029:1-(5-chloro-1-((2,4-dimethoxyphenyl)sulfonyl)-3-(2-methoxyphenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl)-4-hydroxy-N,N-dimethyl-2-pyrrolidinecarboxamide; D014151:Anti-Anxiety Agents; D065092:Antidiuretic Hormone Receptor Antagonists; D002250:Carbon Radioisotopes; D007211:Indoles; D011759:Pyrrolidines; D017483:Receptors, Vasopressin